Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T&T trial: adding testosterone to tamoxifen in male breast cancer patients
2021-002170-72Phase 4Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of testosterone and tamoxifen in breast cancer, sponsored by University Medical Center Groningen. Primary endpoint: Safety profile on combined tamoxifen and testosterone treatment. Started Apr 2022; status: terminated.
02
Drugs
testosteronetamoxifen
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2021-002170-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002170-72.